Mr. Michael Perron reports
MTL CANNABIS CORP. ANNOUNCES U.S. LISTING ON THE OTCQB MARKET
MTL Cannabis Corp.'s common shares commenced trading on the OTCQB Venture Market under the symbol MTLNF as of the opening of markets today. The company's shares will continue to trade on the Canadian Securities Exchange under the symbol MTLC.
The listing on the OTCQB is a step in enhancing the company's visibility and accessibility for United States investors. This milestone is expected to improve liquidity and expand MTL's reach into the U.S. investment market.
"The OTCQB listing marks a significant milestone for MTL Cannabis Corp. as we expand our presence and accessibility in the U.S. market," said Michael Perron, chief executive officer of MTL Cannabis. "This step underscores our commitment to growing shareholder value by reaching a broader investor base, increasing liquidity and positioning MTL Cannabis Corp. as a key player in the global cannabis industry. The U.S. market's depth and engagement present opportunities for the company's continued growth and development."
The OTCQB provides an established platform for early-stage and growth companies to enhance their visibility in the U.S. market. Companies listed on OTCQB must meet rigorous reporting standards, undergo annual verification and comply with management certification requirements, providing investors with a trusted market for trading. Real-time quotes and market information on MTL Cannabis can be found on the OTC (over-the-counter) markets website.
About MTL Cannabis Corp.
MTL Cannabis is the parent company of: Montreal Medical Cannabis Inc. (MTL Cannabis), a licensed producer operating from a 57,000-square-foot licensed indoor grow facility in Pointe Claire, Que.; Abba Medix Corp., a licensed producer in Pickering, Ont., which operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Que., growing best-in-class indoor cannabis in its 64,000-square-foot production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.
As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, prerolls and hash marketed under the MTL Cannabis, Low Key by MTL and R'belle brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP (good agricultural and collection practices) quality cannabis.
It is MTL's goal for Abba Medix to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services.
We seek Safe Harbor.
© 2025 Canjex Publishing Ltd. All rights reserved.